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a b s t r a c t
Depleted uranium (DU) is a high density heavy metal that has been used in military munitions since the
1991 Gulf War. DU is weakly radioactive and chemically toxic. Long term exposure can cause adverse
health effects. This study assessed genotoxic effects in DU exposed Gulf War I veterans as a function
of uranium (U) body burden. Levels of urine U were used to categorize the cohort into low and high
exposure groups. Exposure to DU occurred during friendly fire incidents in 1991 involving DUmunitions
resulting in inhalation and ingestion exposure to small particles of DU and soft tissue DU fragments from
traumatic injuries. All of these Veterans are enrolled in a long term health surveillance program at the
BaltimoreVeteransAdministrationMedicalCenter. Bloodwasdrawn from35exposedmaleveteransaged
36–59 years, then cultured and evaluated for micronuclei (MN) using the cytokinesis block method. The
participants were divided into two exposure groups, low and high, based on their mean urine uranium
(uU) concentrations. Poisson regression analyses with mean urine U concentrations, current smoking,
X-rays in the past year and donor age as dependent variables revealed no significant relationships with
MN frequencies. Our results indicate that on-going systemic exposure to DU occurring in Gulf War I
Veterans with DU embedded fragments does not induce significant increases in MN in peripheral blood
lymphocytes compared to MN frequencies in Veterans with normal U body burdens.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Depleted uranium (DU) is a heavymetal that is both radioactive
and hazardous due to its chemical properties. Natural U is com-
posed of three U isotopes (U234, U235 and U238). DU is a by-product
of the U enrichment process that natural uranium undergoes in
order to extract the U235 isotope for use in nuclear weapons and
nuclear fuel production. Thus, DU has a lower U235/U238 ratio and is
approximately 40% less radioactive thannaturalU.DUmetal is used
for military applications due to its high density, high pyrophoric-
ity, tensile strength that is similar to steel, high availability, and
low cost. It is ideal for use in armor piercing munitions because it
has self-sharpeningpropertiesupon impact allowing it topenetrate
armor more effectively than other metals. DU dust is formed upon
impact of the projectiles, which is one source of internal inhalation
exposure to DU in the battlefield. The other military application of
DU is for protective tank armor, which can increase inhalation and
ingestion exposures to DUdust if amunition pierces DU armor dur-
∗ Corresponding author at: Department of Biological Sciences, 2117 Biological
Sciences Building, 5047 Gullen Mall, Wayne State University, Detroit, MI 48202-
3917, United States. Tel.: +1 313 577 0736; fax: +1 313 577 6891.
E-mail address: jtucker@biology.biosci.wayne.edu (J.D. Tucker).
ing battle [1]. Under normal conditions, occupants of tankswithDU
armor are also exposed to increased amounts of DU-derived radia-
tion. However, this additional radiation dose is very small and does
not constitute a significant health risk [2]. The heavymetal toxicity
of DU is generally considered to present a greater health hazard
than its radioactivity.
External exposure to DU does not present a significant health
hazard, but internal exposure via dust particle inhalation and
embedded DU fragments may lead to adverse health effects due to
both chemical and radiological toxicity. In vitro studies in human
cell lines treatedwith solubleDUcompounds showincreased trans-
formation to tumorigenic phenotypes; several bacterial strains
show increased mutagenic activity after DU exposure and ani-
mal models implanted with DU pellets developed local tumors [3].
These results suggest that DU may increase the risk of cancer [4].
However, in contrast to the animal and in vitro studies, humans
exposed to high internal and external doses of DU do not appear
to suffer measurable health effects [5,6]. For 18 years, the Depart-
ment of Veterans Affairs (VA) has been monitoring the health of
Gulf War I veterans that were exposed to DU during friendly fire
incidents. In addition to inhalation and ingestion exposures, about
forty percent of this cohort sustained traumatic injury resulting in
embedded fragments of DU being retained in soft tissue. During
biennial visits to the Baltimore VA Medical Center, the veterans
1383-5718/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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Table 1




Gender (% males) 35 100
Race
African American 12 34%
Asian American 1 3%
Caucasian 20 57%
Hispanic 2 6%
Participants with embedded DU fragments 15 43%
Agea 43.62±5.35
a Mean age at time of 2009 evaluation (+ standard deviation).
are monitored for the concentration of DU in their urine, for clin-
ical chemistry measures that assess organ system function with
a focus on biomarkers of adverse effects on the renal and repro-
ductive systems, and for hematological, neuroendocrine and bone
metabolism parameters. Additional tests have included measures
of chromosomal aberrations andHPRTmutation frequency inblood
lymphocytes. To date, no clinically significant DU-related health
effects have been observed, even in subjects with the highest urine
uranium concentrations [7–14].
Enumeration of micronuclei (MN) in peripheral blood lympho-
cytes (PBLs) is a well-established cytogenetic method for detecting
chromosome damage caused by radiation and chemical exposures
in humans [15]. Here we used the cytokinesis-blockedMN assay to
measure the number of MN found in the PBLs of DU-exposed Gulf
War I veterans enrolled in the VA monitoring program. The goal of
this study was to determine whether DU exposure as measured by
urine U concentration results leads to detectable levels of cytoge-
netic damage. The results indicate that chronic systemic exposure
toDU inGulfWar I Veteranswith embeddedDU fragments does not
result in elevated frequencies of MN in peripheral blood lympho-
cytes compared to the frequencies of MN in Veterans with normal
U body burdens.
2. Materials and methods
2.1. Recruitment of subjects
The number of micronuclei present in peripheral blood lymphocytes was mea-
sured in blood samples collected from 35 members of the Veteran Administration
(VA)’s DU-exposed GulfWar I veteran cohort who participated in the 4-daymedical
surveillance visit at the Baltimore VAMedical Center (Baltimore,MD) between April
and June 2009. Although all 79 members of this cohort were invited to participate
in this surveillance visit, only about half of the total cohort accepted the invitation
due to personal, employment or military service schedule constraints. One partici-
pant was excluded from this examination of micronuclei because he had previously
received Cobalt radiation therapy. Demographics for the group of 35 veterans that
were examined formicronuclei in blood lymphocytes are shown in Table 1. Approxi-
mately 43% of the veterans in this group had evidence of embedded fragmentswhen
examined by X-ray.
2.2. Blood collection, cell culturing, slide preparation and staining, and
micronuclei analysis
Blood was drawn using 6mL green topped vacutainer tubes containing hep-
arin. The tubes were kept on a tilt shaker at low speed until they were prepared
for shipping (within 2h). The blood samples were shipped overnight from the Bal-
timore VA Medical Center to Wayne State University with ice packs to remain cold
(approximately 4 ◦C). Samples were stored at 4 ◦C upon arrival for 1–2h before
culturing.
Lymphocytes were isolated by carefully layering 2mL of blood diluted with
2mL Hank’s Balanced Salt Solution (HBSS) over 3mL Lymphocyte Separation
Medium (Mediatech, Inc.), then centrifuged at 400× g at room temperature for
30min. The mononuclear cell layer was transferred to a new tube and mixed
with 4mL HBSS, then centrifuged for 10min at 260× g at room temperature.
The cell pellet was washed twice with 4mL HBSS and centrifuged for 10min at
260× g at room temperature. The pellet was then re-suspended in 1mL RPMI
1640 medium (Hyclone), supplemented with 15% Fetal Bovine Serum (Atlanta Bio-
logicals), penicillin–streptomycin (100units/mL penicillin G sodium, 100g/mL
streptomycin in0.85% saline,Gibco), 0.02mg/mLPHA (Gibco) and2mM l-glutamine
(Gibco). A cell count of the 1mL cell suspension was obtained and cultures were
seeded at a concentration of approximately 500,000 cells/mL. Cells were incubated
in a fully humidified incubator with 5% CO2 at 37 ◦C in T25 suspension culture flasks
(Corning) for 44h, then treated with Cytochalasin B (Sigma–Aldrich) (6g/mL final
concentration) and cultured for an additional 28h for a total culture time of 72h.
Cells were re-suspended in their culture medium with a transfer pipette to break
up cell clumps. The cells were then spun onto pre-cleaned microscope slides using
a cytocentrifuge (Stat-Spin) for 4min at 1300 RPM. The slides were air dried and
fixed in 100%methanol for 15min, then dried and stored at room temperature until
staining. Slides were stainedwith 10% Giemsa Solution in Sorenson’s buffer (67mM
Na2HPO4, 67mMKH2PO4 pH6.8) for 15min, rinsed briefly in distilledH2O, air-dried
and then mounted with Permount (Fisher Scientific) and a glass coverslip.
All blood samples were coded prior to shipping to the cytogenetics laboratory.
The code was not broken until all the slide scoring had been completed. A total
of 2000 binucleated cells was scored from each donor under a light microscope
(Nikon Eclipse E200) by 2 trained individuals each of whom scored 1000 cells. Only
intact, binucleated cells with clearly distinct nuclei were scored [16]; the number
of micronuclei (MN) per sample as well as the number of cells with 0, 1, 2, 3, 4, and
5 or more MN were recorded. Binucleated cells containing nucleoplasmic bridges
were excluded from scoring. The Nuclear Division Index (average number of nuclei
per cell) was also determined for each sample.
2.3. Urine uranium analysis
At each biennial health surveillance visit, twenty-four hour urine samples are
collected from each subject and shipped to the Armed Forces Institute of Pathology,
Department of Environmental Toxicologic Pathology (Washington, DC) for analysis
of total uranium using a previously described inductively coupled plasma-dynamic
reaction cell-mass spectrometer (ICP-DR-MS) method [10,17]. Urine U concentra-
tions are standardized on the basis of urine creatinine concentrations to obtain
micrograms of U per gram of creatinine to account for urine dilution due to water
intake and/or dehydration [12,18].
2.4. Uranium exposure metric
A mean urine U (uU) exposure metric for each participant in this study was
calculated using all the uU concentrations obtained for a participant each time they
had participated in a surveillance visit at the Baltimore VA between 1994 and 2007.
This U exposure metric, labeled mean uU 2007, was used to determine whether
a relationship exists between mean uU exposure over the past 18 years and the
presence of micronuclei in blood lymphocytes.
2.5. Statistical analysis
The Mann–Whitney U test was used to test for the significance of differences
observed between High versus Low U exposed groups established based on each
participant’s mean uU 2007 value. Historically, the Baltimore VA DU health surveil-
lance program has used a cut-off value of 0.1g U/g creatinine for dividing High
from Low exposed individuals [8]. This cut-off point was chosen because it was
between the 95th percentile reported by [19] for creatinine-adjusted urine U con-
centrations in U.S. populations with normal exposure to natural U through their
diet and drinking water (0.034g/g creatinine) and 0.35g/L, a value reported as a
uU upper limit in populations living in areas where natural U is elevated in water
and food [20]. Differences were considered statistically significant when calculated
p values were <0.05.
Data were also analyzed using regression analysis. Since micronuclei frequency
is adiscretevariable createdbyacount, PoissonorNegativeBinomialprobabilitydis-
tribution is indicated formultivariate analysis [21]. Poisson distribution can be used
when themean equals the variance but the negative binomial is indicatedwhen this
assumption is violated (e.g., by over-dispersion). The use of the Poisson regression
to estimate the association of micronuclei abnormality frequency with urine ura-
nium adjusting for age, current smoking and X-ray exposure during the past year
was examined using the statistical package STATA version 11 (StataCorp, College
Station, TX). Because of over-dispersion of the data, the results of the equivalent
negative binomial distribution are reported.
3. Results
A total of 35 veteranswere evaluated for the formation ofMN as
a function of their urine U concentrations. All subjects were adult
males, ranging from 36 to 59 years of age. Table 2 shows the ages
of each subject, the mean urine uranium concentrations calculated
for each individual (mean uU 2007) and theMNdata obtained from
each subject. Cells with 0, 1, 2, 3, 4, 5 and >5 MN were observed.
To examine the relationship between MN frequency and U
body burden, the participants in this cohort were divided into two
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Table 2
Urine uranium concentrations and micronuclei data by donor and exposure group.
Donor code Urine [U] (g
U/g cre)







Index (mean # of
nuclei per cell)
High exposure group (>0.1gU/g cre)
102 0.81 38.59 1948 52 38.0 1.31
104 32.61 51.47 1976 24 12.5 1.28
105 40.40 41.74 1967 33 18.0 1.48
115 0.12 41.83 1967 33 18.5 1.72
116 0.46 50.49 1963 37 21.5 1.34
122 1.58 45.9 1978 22 14.0 1.39
123 1.56 39.18 1975 25 14.0 1.74
129 2.19 44.03 1980 20 12.0 1.46
145 12.7 56.06 1947 53 32.5 1.15
193 3.98 45.86 1937 63 42.0 1.47
199 2.5 44.81 1971 29 18.0 1.66
201 0.15 40.3 1983 17 12.0 1.62
202 0.39 40.96 1980 20 11.5 1.85
Mean 7.65 44.71 1967 32.92 20.35 1.50
S.D. 13.32 5.24 14.59 14.59 10.42 0.21
Low exposure group (<0.1gU/g cre)
101 0.064 41.78 1927 73 43.5 1.45
110 0.007 42.49 1989 11 8.5 1.48
119 0.005 48.84 1966 34 21.0 1.54
126 0.016 38.54 1972 28 18.0 1.57
130 0.010 40.37 1963 37 19.5 1.55
134 0.005 42.66 1984 16 10.5 1.63
143 0.027 42.6 1968 32 18.5 1.34
174 0.011 36.73 1976 24 13.0 1.48
176 0.004 52.49 1972 28 17.5 1.51
179 0.011 41.69 1982 18 9.0 1.51
183 0.005 59.83 1952 48 30.0 1.33
186 0.003 41.74 1949 51 29.5 1.48
187 0.002 39.49 1974 26 13.5 1.64
188 0.008 41.71 1977 23 16.5 1.31
190 0.015 44.33 1980 20 12.0 1.45
194 0.011 49.58 1957 43 27.0 1.51
200 0.009 43.85 1982 18 9.5 1.18
204 0.004 38.87 1970 30 19.0 1.44
205 0.006 38.55 1936 64 34.5 1.31
207 0.017 38.19 1978 22 12.0 1.37
210 0.002 42.13 1963 37 19.0 1.34
212 0.009 38.62 1980 20 10.5 1.33
Mean 0.011 42.96 1968 31.95 18.73 1.44
S.D. 0.013 5.43 15.7 15.72 9.15 0.12
groups based on their mean uU2007 exposure metric, with the
Low group consisting of all individuals with mean urine U con-
centrations below 0.1g U/g creatinine and the individuals in the
High grouphaving concentrations equal to or above 0.1g/g creati-
nine. The value of 0.1gU/g creatininewas chosen as the cut-point
between the high and low groups based on its close proximity to
the 95th percentile upper limit value reported by NHANES (2003)
for the concentration of natural U in urine the U.S. population
(0.043g/g creatinine). Twenty-two (22) samples were placed in
the Low group withmean urine [U] ranging from 0.002g U/g cre-
atinine to 0.064g U/g creatinine while 13 samples in the High
group ranged from 0.12g U/g creatinine to 40.41g U/g creati-
nine. The effect of a high U burden on two MN outcome measures,
(1) the number of cells with MN, or (2) the total number of MN
per 2000 cells, was determined by comparing the mean values for
these two parameters in the Low versus High groups. The mean
number of cells with MN was 32.9 in the High group versus 32.0
in the Low group; while the average number of MN/1000 binucle-
ated cells in the Low groupwas 18.7 versus 20.4 for the High group.
Statistical analysis of the data using the Mann Whitney test of sig-
nificant difference indicated that themeans of the Low versus High
groups were not significantly different at the 0.05 level for either
parameter.
Because micronuclei results are discrete variables created by a
count, a more acceptable analysis for examining continuous rela-
tionships betweendata is the PoissonorNegative Binomial analysis
[21]. No significant relationshipswere observed between themean
uU2007 exposure metric and MN frequency when mean uU2007
wasexaminedby itself (Fig. 1)orwhencovariates (current smoking,
X-rays in the past year and age) were included in the analysis (data
not shown). The relationship between the number of cells with
MN and age was also examined and is shown in Fig. 2. There was
no significant relationship between MN frequency and age when
examined separately or when controlled for uU concentrations,
smoking and X-rays in the past year (data not shown).
4. Discussion
The results of our study show no difference in MN frequency
in the high versus low urine U groups. This conclusion is consis-
tent with other results from the DU surveillance program which
has been monitoring the health of these veterans since the 1991
Gulf War. The surveillance program has not detected any signif-
icant health effects that can be attributed to DU exposure, even
in those veterans with DU shrapnel in their bodies [8]. Urine Ura-
nium levels in most of the veterans in the DU exposed cohort are
similar to the general U.S. population and only remain elevated in
veterans with embedded DU fragments [5]. In a previous assess-
ment of this DU-exposed ‘friendly-fire’ cohort, a group of Gulf War
I deployed, but non-DU-exposed controls was evaluated [12]. The




























Fig. 1. Relationship between micronuclei frequency (MN/1000 cells) and the nat-
ural log of urine uranium concentrations of Gulf War I veterans exposed to DU.
No significant relationship exists between urine U excretion and the frequency of
micronuclei in blood lymphocytes. Members of the cohort were separated into Low
versus High uU groups based on themean of their past urine U concentrations (Low
uU concentrations are <0.1g U/g creatinine; High uU concentrations are >0.1g
U/g creatinine).
urine U distribution of the non-DU exposed veterans was found
to be similar to the cohort of veterans that are DU-exposed but
without embedded fragments; these values were also within the
normal range for the U.S. population. Thus, using uU as a measure
of U body burden, the low uU group within the friendly-fire cohort
of DU exposed veterans provides an appropriate comparison group
for the veterans with embedded DU fragments who have high uU
concentrations.
We hypothesized that veterans with substantial numbers of
DU fragments embedded in their bodies may have elevated MN
frequencies due to the prolonged and constant systemic DU expo-
sure they experience. DU causes radiation exposure because it is a
radioactive metal which naturally emits alpha particles along with
beta and gamma radiation during the decay process [2]. The alpha
particles are high energy but have low penetrating power and they
can be a potential internal hazard when DU is inhaled, ingested
or found in wounds. The beta and gamma radiation are generally
external exposure hazards, however, the overall radioactivity of DU
is very low [4]. Existing experimental evidence also suggests that

























Age of Subjects at Sampling Time
Low High
Fig. 2. Relationship between micronuclei frequency (MN/1000 cells) and the age
of each veteran at the time of sampling. No significant relationship exists between
age and the frequency of micronuclei in blood lymphocytes. Members of the cohort
were separated into Low versus High uU groups based on the mean of their past
urine U concentrations (Low uU concentrations are <0.1g U/g creatinine; High uU
concentrations are >0.1g U/g creatinine).
These data do not support our original hypothesis that MNmay
be elevated in veterans with a chronically elevated U body bur-
den due to embedded DU fragment retention. A possible physical
explanation for this finding is that the embedded fragments are
not close enough to the blood supply to cause any visible damage
to the passing lymphocytes, either by emission of poorly penetrat-
ing alpha particles or by chemical toxicity. If many DU fragments
are located close to large blood vessels, it would bemore likely that
radiation or chemical toxicity effects could be seen in the lympho-
cytes. The cells in the tissue surrounding the shrapnel would suffer
the most damage from DU, and these effects would diminish with
distance from the metal. Detailed information about the size, loca-
tions, and number of fragments embedded in each individual is not
available.
Although no significant relationship between elevated MN and
uUconcentrationwasobserved in this study,DUexposuremay lead
to small increases inmicronucleus frequencies in some individuals
but these increases are too low to be detectable. The effect of DU
exposure could be masked by factors that are known to influence
MN frequencies, such as age and cigarette smoking. MN frequen-
cies are known to increase with age [15,25], yet we do not see
an age effect present in our results, probably due to the relatively
small sample size. Cigarette smoking can also be a factor in heavy
smokers. The Human MicroNucleus Project examined the effects
of smoking onMN frequencies in multiple studies involving nearly
6000 subjects. These analyses indicate that smokers do not have
more MN than non-smokers, and even show a small decrease in
MN frequencies. However, heavy smokers (at least 30 cigarettes
per day) do show increases which can only be observed in people
who are not occupationally exposed to genotoxic agents [26]. We
controlled for current smoking (yes/no) in our regression analysis,
but did not have information on the number of cigarettes smoked
per day for each individual.
Exposure to ionizing radiation can also lead to increasedMN fre-
quencies, thuswe controlled for past exposure to x-rays as reported
by the veterans. Many receivedmultiple X-rays or other diagnostic
procedures following their injuries, however controlling for num-
ber of X-rays in the past year did not alter the relationship between
MN and mean uU concentrations.
Only one other study has usedmicronuclei to evaluate individu-
als with environmental exposure to DU. Krunic et al. [27] recruited
individuals from areas of Bosnia and Herzegovina where DUmuni-
tions were used during the Balkan conflict. A control population
was recruited from West Herzegovina which was not impacted
by war activities. Results of this study showed a small increase
in the MN frequency in the exposed group compared to controls.
However, there was no control for exposure to other genotoxic
chemicals, and DU exposure was not directly measured in indi-
vidual subjects but was assumed based on the presence of DU in
environmentalmatrices [27].Other importantdifferencesalsoexist
between their study design and the onewe report here. Krunic et al.
evaluated individuals thought to be exposed to DU dust through
direct contact and aerosol inhalation, but did not include subjects
with embedded shrapnel. Their control group consisted of unex-
posed individuals while our Low group consisted of individuals
with previous exposure to DU but low urine U concentrations.
Depleted uranium exposure can be external (skin contact)
and internal (ingestion, inhalation and embedded fragments) and
present both radiological and chemical hazards. However, the lev-
els of exposure that occurred during the 1991GulfWar did not lead
to significant increases in body burdens above non-exposed popu-
lations [2] except in the cases involving embedded DU fragments.
This study concurs with others showing that the DU exposure that
occurred in GulfWar I veteranswith embedded DU fragments does
not appear to increase biomarkers of genotoxic damage despite an
ongoing elevation of their U body burdens for over 18 years.
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